The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring the association between renal cell carcinoma (RCC) and myeloid malignancies.
 
Niraj Konchady Shenoy
No Relationships to Disclose
 
Mythri Mudireddy
No Relationships to Disclose
 
Nelson Leung
Research Funding - Omeros
 
Brian Addis Costello
No Relationships to Disclose
 
Bradley C. Leibovich
No Relationships to Disclose
 
Robert Houston Thompson
Patents, Royalties, Other Intellectual Property - Patent for B7-H1 and survivin as prognostic markers in renal cell carcinoma.
 
Lance C. Pagliaro
Travel, Accommodations, Expenses - Roche
 
Thomas E. Witzig
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Consulting or Advisory Role - Celgene; Seagen
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst)
 
Fang-Shu Ou
No Relationships to Disclose
 
Tamas Ordog
No Relationships to Disclose
 
Mrinal Mahesh Patnaik
No Relationships to Disclose
 
Ayalew Tefferi
No Relationships to Disclose
 
Kebede Begna
No Relationships to Disclose